Higher-Risk Myelodysplastic Syndromes | David Sallman, MD

Inside the Issue: Novel Agents, Approaches and Strategies in the Management of Higher-Risk Myelodysplastic Syndromes — Faculty Presentation 2: Future directions in the management of higher-risk MDS  — Dr David Sallman CME information and select publications